Related Experiment Video

Updated: Sep 20, 2026

A Three-dimensional Tissue Culture Model to Study Primary Human Bone Marrow and its Malignancies
08:51

A Three-dimensional Tissue Culture Model to Study Primary Human Bone Marrow and its Malignancies

Published on: March 8, 2014

Marrow fibroblasts from patients with myeloproliferative disorders show increased sensitivity to human serum mitogens

A Kimura1, O Katoh, A Kuramoto

  • 1Department of Internal Medicine, Research Institute for Nuclear Medicine and Biology, Hiroshima University, Japan.

British Journal of Haematology
|June 1, 1988
PubMed

Insights

Fibroblast growth in myeloproliferative disorders (MPD) patients is elevated, particularly in chronic myelocytic leukaemia and essential thrombocythaemia. MPD fibroblasts show increased sensitivity to plasma factors, potentially explaining myelofibrosis development.

Area of Science:

  • Hematology
  • Cell Biology
  • Oncology

Background:

  • Myeloproliferative disorders (MPD) are a group of clonal hematopoietic stem cell diseases.
  • Myelofibrosis is a serious complication characterized by bone marrow fibrosis.

Purpose of the Study:

  • To investigate the proliferation of marrow fibroblasts from MPD patients.
  • To determine the role of platelet-derived growth factor (PDGF) and plasma-derived serum in fibroblast proliferation in MPD.

Main Methods:

  • Culturing marrow fibroblasts from MPD patients and normal individuals.
  • Stimulating fibroblast growth using platelet-derived growth factor (PDGF) and human serum.
  • Assessing proliferation rates in the presence of human plasma-derived serum.

Main Results:

  • Fibroblast proliferation was significantly increased in MPD patients compared to normal controls.
  • The increase was particularly notable in patients with chronic myelocytic leukaemia and essential thrombocythaemia.
  • MPD fibroblasts demonstrated higher sensitivity to plasma-derived serum than to PDGF.

Conclusions:

  • MPD fibroblasts exhibit heightened sensitivity to specific factors present in plasma.
  • This increased sensitivity may contribute to the pathogenesis of myelofibrosis in MPD.
  • Further research into plasma-derived factors is warranted to understand MPD progression.

More Related Videos

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Colony-Forming Unit Assay Adapted For Patient-Derived Bone Marrow and Peripheral Blood Mononuclear Cells08:50

Colony-Forming Unit Assay Adapted For Patient-Derived Bone Marrow and Peripheral Blood Mononuclear Cells

Published on: June 26, 2026

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...